+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Estrogens decrease gamma-ray-induced senescence and maintain cell cycle progression in breast cancer cells independently of p53

Estrogens decrease gamma-ray-induced senescence and maintain cell cycle progression in breast cancer cells independently of p53

International Journal of Radiation Oncology, Biology, Physics 67(4): 1187-1200

Purpose: Sequential administration of radiotherapy and endocrine therapy is considered to be a standard adjuvant treatment of breast cancer. Recent clinical reports suggest that radiotherapy could be more efficient in association with endocrine therapy. The aim of this study was to evaluate the estrogen effects on irradiated breast cancer cells (IR-cells).Methods and Materials: Using functional genomic analysis, we examined the effects of 17-beta-estradiol (E-2, a natural estrogen) on MCF-7 breast cancer cells.Results: Our results showed that E-2 sustained the growth of IR-cells. Specifically, estrogens prevented cell cycle blockade induced.by gamma-rays, and no modification of apoptotic rate was detected. In IR-cells we observed the induction of genes involved in premature senescence and cell cycle progression and investigated the effects of E2 on the p53/p21(waf1/cip1)/Rb pathways. We found that E-2 did not affect p53 activation but it decreased cyclin E binding to p21(waf1/cip1) and sustained downstream Rb hyperphosphorylation by functional inactivation of p21(waf1/cip1). We suggest that Rb inactivation could decrease senescence and allow cell cycle progression in IR-cells.Conclusion: These results may help to elucidate the molecular mechanism underlying the maintenance of breast cancer cell growth by E-2 after irradiation-induced damage. They also offer clinicians a rational basis for the sequential administration of ionizing radiation and endocrine therapies.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 013243307

Download citation: RISBibTeXText

PMID: 17336220

DOI: 10.1016/j.ijrobp.2006.11.040

Related references

BAG-1 inhibits PPAR gamma-induced cell death, but not PPAR gamma-induced transcription, cell cycle arrest or differentiation in breast cancer cells. Oncology Reports 19(3): 689-696, 2008

Cyclin D1 is necessary for tamoxifen-induced cell cycle progression in human breast cancer cells. Cancer Research 66(23): 11478-11484, 2006

Regulation of interactions between the cell cycle inhibitors and other cycle regulators and cell cycle progression in cancer cells by gamma linolenic acid. Proceedings of the American Association for Cancer Research Annual Meeting 39: 91, 1998

Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells. Molecular and Cellular Biology 26(7): 2501-2510, 2006

RalGPS2 Is Essential for Survival and Cell Cycle Progression of Lung Cancer Cells Independently of Its Established Substrates Ral GTPases. Plos one 11(5): E0154840, 2016

Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells. Cell Growth & Differentiation 7(1): 65-74, 1996

Pharmacologic p53 activation blocks cell cycle progression but fails to induce senescence in epithelial cancer cells. Molecular Cancer Research 7(9): 1497-1509, 2009

Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells. Journal of Biological Chemistry 277(32): 28815-28822, 2002

Down-regulation of Orai3 arrests cell-cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells. Journal of Cellular Physiology 226(2): 542-551, 2011

Gamma-Linolenic acid blocks cell cycle progression byh regulating phosphorylation of p27kip1 and p57kip2 and their interactions with other cycle regulators in cancer cells. International Journal of Oncology 13(3): 611-617, 1998

Prolactin-induced protein is required for cell cycle progression in breast cancer. Neoplasia 16(4): 329-42.E1-14, 2014

Estrogen regulation of cell cycle progression in breast cancer cells. Journal Of Steroid Biochemistry & Molecular Biology. 65(1-6): 169-174, Il, 1998

Effect of interferon-gamma on growth and cell cycle progression of stomach cancer cells. Gastroenterology 114(4 Part 2): A634, 1998

Epidermal growth factor-induced nuclear factor kB activation: a major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 97(15): 42-7, 2000